Rinvoq ER 45 MG tablet UU 28S
Ended Awarded Last action
- Contract number
- SPE2DR26F21NJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,112
Award facts
- Contract value 100% obligated
- $72,112.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $72,112.38 firm fixed-price delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 29, 2026, with a completion date of January 30, 2026. The delivery order covers RINVOQ ER 45 mg tablets (quantity 28 units), a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions. This non-set-aside award was made through competitive procedures and represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where Amerisourcebergen Drug Corp maintains its corporate headquarters and operates as a major pharmaceutical distributor serving federal medical procurement needs.
This delivery order is part of Amerisourcebergen's comprehensive $999,999,999 IDC with DLA Troop Support Medical (designated SPE2DX and running through December 2026), which enables the company to supply pharmaceutical products and medical commodities to support military healthcare programs globally. Cencora, Inc., the parent company, holds a separate $999,999,999 IDC with the same agency extending through December 2031. The company's federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems on a competitively awarded basis.
Quick answers
Who was awarded contract SPE2DR26F21NJ?
SPE2DR26F21NJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F21NJ worth?
The government has obligated $72,112 on SPE2DR26F21NJ.
Is contract SPE2DR26F21NJ an order under another contract?
Yes. SPE2DR26F21NJ is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21NJ competed?
The extent of competition for SPE2DR26F21NJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award